Intelligence · Clinical Development
Pipeline search results
Programs matching “covid-19” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 147 pipeline programs matching "covid-19" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Recombinant COVID-19 Vaccine (CHO cell)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19 Pneumonia
1 trial -
Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-08)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19 Pneumonia
1 trial -
Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-09)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
Sargramostim
United Therapeutics Europe Ltd
COVID-19
1 trial -
Sotrovimab
Vir Biotechnology
COVID-19
1 trial -
TAK-919
Takeda
Coronavirus Disease (COVID-19)
1 trial -
TD-0903
Theravance Biopharma Ireland Umited
Acute Lung Injury (ALI) Associated With COVID-19
2 trials -
THALASSA 2.0
MEDA Pharma GmbH & Co. KG
post-COVID-19 Condition (PCC)
1 trial -
Tafenoquine Oral Tablet
60 DEGREES PHARMACEUTICALS, INC.
COVID 19 Disease
1 trial -
UB-612
United Therapeutics Europe Ltd
COVID-19
4 trials -
Ursodeoxycholic acid
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
Vortioxetine
COGNITION THERAPEUTICS INC
Post-COVID-19 Condition
1 trial -
casirivimab+imdevimab
Regeneron UK Limited
COVID-19
2 trials -
lanadelumab
Takeda
COVID-19
1 trial -
low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
placebo
The First People's Hospital of Lianyungang
COVID-19 Thalidomide
1 trial -
A clinical study of MK-1289 in healthy adult men (MK-1289-001)
Merck Sharp and Dohme
COVID-19 Infection
1 trial -
ALG-097558
Aligos Therapeutics
COVID-19
3 trials -
APR002
BRIGHT MINDS BIOSCIENCES INC.
COVID-19
1 trial -
Bempegaldesleukin
Nektar Therapeutics UK Limited
Covid-19
1 trial -
CLBS119
LISATA THERAPEUTICS, INC.
Covid-19
1 trial -
COVID-HIGIV
United Therapeutics Europe Ltd
COVID-19
1 trial -
CPI-006
Corvus Pharmaceuticals
COVID-19
1 trial -
CSL760
CSL Behring GmbH
Coronavirus Disease 2019 (COVID-19)
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.